Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-210700
Filing Date
2020-08-05
Accepted
2020-08-05 16:38:30
Documents
8
Effectiveness Date
2020-08-05

Document Format Files

Seq Description Document Type Size
1 S-8 d50479ds8.htm S-8 79174
2 EX-5.1 d50479dex51.htm EX-5.1 9614
3 EX-5.2 d50479dex52.htm EX-5.2 10111
4 EX-23.1 d50479dex231.htm EX-23.1 1877
5 GRAPHIC g50479n1.jpg GRAPHIC 4154
6 GRAPHIC g50479n2.jpg GRAPHIC 2600
7 GRAPHIC g50479n3.jpg GRAPHIC 93012
8 GRAPHIC g50479n4.jpg GRAPHIC 2981
  Complete submission text file 0001193125-20-210700.txt   243767
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-241003 | Film No.: 201078182
SIC: 2834 Pharmaceutical Preparations